EDGAR Filing Documents for 0001193125-23-176795

Form 8-K - Current report:

SEC Accession No. 0001193125-23-176795

Filing Date

2023-06-28

Accepted

2023-06-28 08:00:34

Documents

Period of Report

2023-06-27

Items

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d506361d8k.htm iXBRL	8-K	31581
2	EX-3.1	d506361dex31.htm	EX-3.1	5012
3	EX-99.1	d506361dex991.htm	EX-99.1	29544
7	GRAPHIC	g506361ex99_1p10g1.jpg	GRAPHIC	282089
8	GRAPHIC	g506361ex99_1p11g1.jpg	GRAPHIC	307276
9	GRAPHIC	g506361ex99_1p12g1.jpg	GRAPHIC	262311
10	GRAPHIC	g506361ex99_1p13g1.jpg	GRAPHIC	240162
11	GRAPHIC	g506361ex99_1p14g1.jpg	GRAPHIC	250130
12	GRAPHIC	g506361ex99_1p15g1.jpg	GRAPHIC	182791
13	GRAPHIC	g506361ex99_1p16g1.jpg	GRAPHIC	330940
14	GRAPHIC	g506361ex99_1p17g1.jpg	GRAPHIC	270929
15	GRAPHIC	g506361ex99_1p18g1.jpg	GRAPHIC	258349
16	GRAPHIC	g506361ex99_1p19g1.jpg	GRAPHIC	332750
17	GRAPHIC	g506361ex99_1p1g1.jpg	GRAPHIC	346719
18	GRAPHIC	g506361ex99_1p20g1.jpg	GRAPHIC	372348
19	GRAPHIC	g506361ex99_1p21g1.jpg	GRAPHIC	314958
20	GRAPHIC	g506361ex99_1p22g1.jpg	GRAPHIC	301460
21	GRAPHIC	g506361ex99_1p23g1.jpg	GRAPHIC	251109
22	GRAPHIC	g506361ex99_1p24g1.jpg	GRAPHIC	237791
23	GRAPHIC	g506361ex99_1p25g1.jpg	GRAPHIC	371392
24	GRAPHIC	g506361ex99_1p26g1.jpg	GRAPHIC	241686
25	GRAPHIC	g506361ex99_1p2g1.jpg	GRAPHIC	367880
26	GRAPHIC	g506361ex99_1p3g1.jpg	GRAPHIC	263316
27	GRAPHIC	g506361ex99_1p4g1.jpg	GRAPHIC	301510
28	GRAPHIC	g506361ex99_1p5g1.jpg	GRAPHIC	359289
29	GRAPHIC	g506361ex99_1p6g1.jpg	GRAPHIC	370068
30	GRAPHIC	g506361ex99_1p7g1.jpg	GRAPHIC	271618
31	GRAPHIC	g506361ex99_1p8g1.jpg	GRAPHIC	327170
32	GRAPHIC	g506361ex99_1p9g1.jpg	GRAPHIC	271366
	Complete submission text file	0001193125-23-176795.txt		10794748

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	mcrb-20230627.xsd	EX-101.SCH	2868
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	mcrb-20230627_lab.xml	EX-101.LAB	17980
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	mcrb-20230627_pre.xml	EX-101.PRE	11270
34	EXTRACTED XBRL INSTANCE DOCUMENT	d506361d8k_htm.xml	XML	3445

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139

Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626

Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)